We are pleased to announce that Transplantation Direct has received its first Impact Factor of 2.3. As a relative newcomer journal in the field, this is a very encouraging initial evaluation that we will continue to build on, and a milestone step forward for the journal.

Our July issue has a broad spectrum of content, including reports in kidney transplantation on the need for follow-up biopsies in cases of TCMR and on first evidence of endocrine activity in normothermic machine perfusion kidneys; in addition, there are case reports on Birt-Hogg-Dubé syndrome with renal cell carcinoma in a living donor transplant and the use of checkpoint inhibitor therapy in a recipient with upper tract urothelial carcinoma. In liver transplantation, a study on important characteristics of new-onset systolic heart failure is presented. There are several reports in lung transplantation, including an assessment of whether ECMO bridging to transplantation increases HLA sensitization, the use of CMV immunity testing to predict viremia, a trial that evaluated safety of transplanting HCV-RNA+ lungs, a study looking at whether DQA1 eplet mismatch load can predict CLAD, and introduction of a multimodal education plan to reduce skin cancer in lung transplant recipients. We have an article in pancreas transplantation on outcomes regarding surgical site infections after peri-operative prophylaxis with enterococcus coverage. On the topic of organ donation, a Canadian group reports on sociodemographic variables at play in their organ donation organizations. For complete details on all these articles, please visit our open access Transplantation Direct website.